Conference Program Home
  My Program

All Times EDT

* = applied session       ! = JSM meeting theme

Activity Details

161 Mon, 8/8/2022, 12:30 PM - 1:50 PM CC-Ballroom Level South Prefunction
Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
Biopharmaceutical Section
ML08: Demonstration of Contribution of Component for Combination Drug Development
Meihua Wang, Alkermes; Linda Sun, Merck & Co, Inc.
ML09: The Tripartite Estimand Approach: When Is it Useful?
Stephen J Ruberg, Analytix Thinking, LLC